We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+32.61%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$610M
AUM Growth
+$17.3M
(+2.9%)
Cap. Flow
-$82.5M
Cap. Flow
% of AUM
-13.54%
Top 10 Holdings %
Top 10 Hldgs %
9.29%
Holding
412
New
138
Increased
22
Reduced
119
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$3.89M |
| 2 |
KZR
Kezar Life Sciences
KZR
|
+$3.86M |
| 3 |
PENG
Penguin Solutions Inc
PENG
|
+$3.7M |
| 4 |
Forward Air
FWRD
|
+$3.51M |
| 5 |
Rambus
RMBS
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OptimizeRx
OPRX
|
+$7.23M |
| 2 |
PLXP
PLx Pharma Inc. Common Stock
PLXP
|
+$7.18M |
| 3 |
PAVmed
PAVM
|
+$6.57M |
| 4 |
EVRI
Everi Holdings
EVRI
|
+$4.68M |
| 5 |
Celldex Therapeutics
CLDX
|
+$4.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Industrials | 18.61% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Richardson Electronics
RELL
$308M
| $1.78M | 0.29% |
+131,741
| New | +$1.52M |
|
152
Ovintiv
OVV
$16B
| $1.78M | 0.29% |
+52,830
| New | +$1.89M |
|
153
Enpro
NPO
$6.95B
| $1.77M | 0.29% |
+16,064
| New | +$1.61M |
|
154
CorVel
CRVL
$3.19B
| $1.74M | 0.29% |
25,113
-6,624
| -21% | -$416K |
|
155
Southern First Bancshares
SFST
$608M
| $1.73M | 0.28% |
+27,702
| New | +$1.63M |
|
|
INBX
156
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.72M | 0.28% |
+39,462
| New | +$1.58M |
|
157
Red Violet
RDVT
$963M
| $1.72M | 0.28% |
43,320
-1,272
| -3% | -$44.4K |
|
158
UFP Technologies
UFPT
$2.49B
| $1.71M | 0.28% |
24,353
-717
| -3% | -$47.5K |
|
159
HUB Group
HUBG
$2.91B
| $1.71M | 0.28% |
+40,584
| New | +$1.61M |
|
|
BRT
160
BRT Apartments
BRT
$267M
| $1.7M | 0.28% |
+70,884
| New | +$1.42M |
|
|
EFOR
161
Everforth Inc
EFOR
$1.3B
| $1.7M | 0.28% |
+13,780
| New | +$1.69M |
|
162
Novanta
NOVT
$5.45B
| $1.7M | 0.28% |
9,624
-5,469
| -36% | -$914K |
|
163
California Resources
CRC
$4.56B
| $1.7M | 0.28% |
39,704
-14,590
| -27% | -$624K |
|
164
Materion
MTRN
$6.18B
| $1.68M | 0.28% |
+18,296
| New | +$1.52M |
|
165
Olin
OLN
$2.13B
| $1.68M | 0.27% |
29,126
-472
| -2% | -$26.5K |
|
166
AdvanSix
ASIX
$546M
| $1.67M | 0.27% |
35,286
-9,580
| -21% | -$441K |
|
|
PFSW
167
DELISTED
PFSweb, Inc.
PFSW
| $1.66M | 0.27% |
128,975
-3,843
| -3% | -$49.6K |
|
|
BRDG
168
DELISTED
Bridge Investment Group
BRDG
| $1.66M | 0.27% |
+66,295
| New | +$1.33M |
|
169
Chord Energy
CHRD
$7.32B
| $1.65M | 0.27% |
+13,105
| New | +$1.56M |
|
170
Belden
BDC
$5.01B
| $1.65M | 0.27% |
+25,074
| New | +$1.57M |
|
171
VSE Corp
VSEC
$6.05B
| $1.65M | 0.27% |
+26,987
| New | +$1.51M |
|
172
Live Oak Bancshares
LOB
$2.03B
| $1.63M | 0.27% |
+18,683
| New | +$1.56M |
|
|
TWNK
173
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.63M | 0.27% |
+79,733
| New | +$1.48M |
|
|
CPRX
174
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.62M | 0.27% |
+239,071
| New | +$1.57M |
|
|
INFA
175
DELISTED
Informatica
INFA
| $1.62M | 0.27% |
+43,759
| New | +$1.48M |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q4 2021 Portfolio in Review
As of Q4 2021, EAM Investors held 412 positions worth $610M, up 2.9% from $593M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
EAM Investors withdrew a net $82.5M in Q4 2021, closing 133 positions and reducing 119 holdings. Its most notable exit was OptimizeRx, an estimated $7.23M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, EAM Investors opened a new position in Impinj worth $4.76M.
- EAM Investors's largest Q4 2021 buy was Impinj: 53,617 shares worth $4.76M.
- EAM Investors added most to BlueLinx in Q4 2021, an estimated $2.56M increase.
- EAM Investors's biggest Q4 2021 reduction was Aehr Test Systems, cutting an estimated $3.65M.
- EAM Investors fully exited OptimizeRx in Q4 2021, selling an estimated $7.23M.
- EAM Investors's ten largest holdings make up 9.3% of its $610M portfolio in Q4 2021.
- EAM Investors opened 138 new positions and closed 133 in Q4 2021.
- EAM Investors's portfolio value rose 2.9% quarter-over-quarter to $610M.
Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.